Icon (ICLR) Operating Income (2009 - 2026)
Icon's (ICLR) quarterly Operating Income came in at $137.8 million in Q2 2026, down 40.32% year-over-year from $230.9 million in Q2 2025, and down 20.67% quarter-over-quarter from $173.7 million in Q1 2026.
Analysis
Icon (ICLR) Operating Income (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Operating Income for 18 consecutive years, with $137.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Income fell 40.32% year-over-year to $137.8 million in Q2 2026; TTM through Jun 2026 was $606.0 million, a 43.56% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 12.62% from the prior year.
- Operating Income was $137.8 million for Q2 2026 at Icon, down from $173.7 million in the prior quarter.
- Over five years, Operating Income peaked at $330.4 million in Q4 2024 and troughed at $86.6 million in Q3 2025.
- A 5-year average of $218.0 million and a median of $221.9 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income jumped 4671.81% in 2022 and plunged 69.67% in 2025, its largest moves.
- Over 5 years, Operating Income stood at $203.4 million in 2022, then grew by 19.75% to $243.5 million in 2023, then jumped by 35.67% to $330.4 million in 2024, then sank by 37.09% to $207.8 million in 2025, then plunged by 33.69% to $137.8 million in 2026.
- The last three Operating Income figures came in at $137.8 million (Q2 2026), $173.7 million (Q1 2026), and $207.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 146.82 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 137.83 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 119.89 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -409,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -6.00 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137.83 Mn |
| Mar 31, 2026 | 173.73 Mn |
| Dec 31, 2025 | 207.85 Mn |
| Sep 30, 2025 | 86.58 Mn |
| Jun 30, 2025 | 230.94 Mn |
| Mar 31, 2025 | 226.97 Mn |
| Dec 31, 2024 | 330.40 Mn |
| Sep 30, 2024 | 285.43 Mn |
| Jun 30, 2024 | 229.86 Mn |
| Mar 31, 2024 | 285.50 Mn |
| Dec 31, 2023 | 243.53 Mn |
| Sep 30, 2023 | 264.31 Mn |
| Jun 30, 2023 | 209.48 Mn |
| Mar 31, 2023 | 216.79 Mn |
| Dec 31, 2022 | 203.36 Mn |
| Sep 30, 2022 | 243.74 Mn |
| Jun 30, 2022 | 177.79 Mn |
| Mar 31, 2022 | 170.34 Mn |
| Dec 31, 2021 | 144.54 Mn |
| Sep 30, 2021 | 5.11 Mn |